<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97457">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01919957</url>
  </required_header>
  <id_info>
    <org_study_id>C12-11</org_study_id>
    <secondary_id>2013-A00343-42</secondary_id>
    <nct_id>NCT01919957</nct_id>
  </id_info>
  <brief_title>Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies</brief_title>
  <acronym>MemO-Epi</acronym>
  <official_title>Etude de la mémoire Avant et après Chirurgie d'Une épilepsie Partielle pharmacorésistante : Bases Neurobiologiques, Applications Cliniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has two purposes: firstly, a better understanding of the neurobiological
      processes underlying episodic memory and, secondly, the development of useful clinical
      applications for epileptic patients, in particular the prediction of postoperative memory
      deficits and the development of cognitive remediation therapies.

      Memory performances during a fMRI experiment will be assessed in controls and epileptic
      patients before and after the surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Measure of successfull encoding</measure>
    <time_frame>8 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Our goal is to define correlation between the measure of successfull object encoding trials (especially for binding) and the beta value activation in fMRI</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Epilepsy, Unspecified, Pharmacologically Resistant</condition>
  <condition>Memory Impairment</condition>
  <arm_group>
    <arm_group_label>memory outcome</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>memory outcome</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with drug-resistant epilepsy

          -  Age of 18 years or more

          -  Follow-up in the epilepsy unit at Pitié-Salpêtrière Hospital

          -  Before or after the presurgical evaluation unit including a video-EEG monitoring, a
             structural  brain imaging and a full neuropsychological assessment

          -  Covered by a social security system

          -  Signing of consent form

        Exclusion Criteria:

          -  Persons under guardianship, curatorship or any other administrative or judicial
             deprivation of rights and freedom

          -  Refusal to consent form

          -  Contraindications to MRI

          -  Pregnancy

          -  Refusal to be informed in the case of detection of an abnormality during the
             experiment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophie Dupont, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Soins de Suites et Réadaptation Neurologique, Hôpital de la Pitié-Salpêtrière, 47/83 Bd de l'Hôpital, 75651 Paris Cedex 13</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophie DUPONT, MD, PhD</last_name>
    <phone>01 42 17 85 23</phone>
    <phone_ext>+33</phone_ext>
    <email>sophie.dupont@psl.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Virginie LAMBRECQ, MD</last_name>
    <email>vlambrecq@hotmail.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>INSERM - Plateau IRM du CENIR, CR-ICM Hôpital Pitié-Salpêtrière, 47/83 Boulevard de l'Hôpital</name>
      <address>
        <city>Paris</city>
        <state>Cedex 13</state>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophie Dupont, MD, PhD</last_name>
      <phone>01 42 17 85 23</phone>
      <phone_ext>+33</phone_ext>
      <email>sophie.dupont@psl.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Virginie Lambrecq, MD</last_name>
      <email>vlambrecq@hotmail.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Sophie Dupont, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie Lambrecq, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véra Dinkelacker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Lehéricy, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lionel Thivard, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claude Adam, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>August 7, 2013</lastchanged_date>
  <firstreceived_date>July 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epilepsy</keyword>
  <keyword>surgery</keyword>
  <keyword>functional MRI</keyword>
  <keyword>memory outcome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsies, Partial</mesh_term>
    <mesh_term>Memory Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
